Astera Labs, Inc. $ALAB Position Reduced by Acadian Asset Management LLC

Key Points

• Acadian Asset Management LLC significantly reduced its stake in Astera Labs by 83.7% in Q1, owning 29,058 shares after selling 149,285 shares during the period.
• Insider transactions at Astera Labs included the CFO selling 100,000 shares for approximately $17.14 million and a director selling 183,000 shares for around $31.71 million, both reflecting substantial decreases in their respective ownership stakes.
• Based on analysts' reports, Astera Labs has received multiple "buy" ratings, with price targets increasing significantly, indicating a bullish outlook for the company's future performance.

Acadian Asset Management LLC decreased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 83.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 29,058 shares of the company's stock after selling 149,285 shares during the quarter. Acadian Asset Management LLC's holdings in Astera Labs were worth $1,730,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company's stock valued at $554,780,000 after buying an additional 85,846 shares during the last quarter. Alliancebernstein L.P. raised its position in shares of Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after buying an additional 4,478,741 shares during the last quarter. Atreides Management LP grew its stake in Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after buying an additional 2,815,614 shares during the last quarter. Fred Alger Management LLC lifted its position in shares of Astera Labs by 13.0% during the first quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after purchasing an additional 179,638 shares in the last quarter. Finally, Altimeter Capital Management LP raised its holdings in Astera Labs by 68.0% in the first quarter. Altimeter Capital Management LP now owns 981,697 shares of the company's stock worth $58,578,000 after purchasing an additional 397,267 shares during the period. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on ALAB. Needham & Company LLC lifted their price objective on shares of Astera Labs from $100.00 to $170.00 and gave the stock a "buy" rating in a research note on Wednesday, August 6th. Citigroup lifted their price target on shares of Astera Labs from $160.00 to $275.00 and gave the stock a "buy" rating in a research note on Wednesday. Jefferies Financial Group lifted their price target on Astera Labs from $95.00 to $130.00 and gave the stock a "buy" rating in a research report on Tuesday, July 22nd. Stifel Nicolaus set a $145.00 price target on Astera Labs and gave the stock a "buy" rating in a research note on Monday, August 4th. Finally, Evercore ISI lifted their target price on Astera Labs from $104.00 to $215.00 and gave the company an "outperform" rating in a research note on Wednesday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Astera Labs presently has a consensus rating of "Moderate Buy" and a consensus target price of $152.94.

Astera Labs Price Performance

NASDAQ ALAB traded down $6.68 during trading on Friday, reaching $245.20. 22,431,313 shares of the company's stock traded hands, compared to its average volume of 4,617,677. The company's 50 day simple moving average is $169.95 and its two-hundred day simple moving average is $109.51. The firm has a market cap of $40.76 billion, a price-to-earnings ratio of 437.86, a price-to-earnings-growth ratio of 6.39 and a beta of 1.48. Astera Labs, Inc. has a 12-month low of $47.00 and a 12-month high of $262.90.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.33 by $0.11. The firm had revenue of $191.93 million during the quarter, compared to analysts' expectations of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The business's revenue was up 149.5% compared to the same quarter last year. During the same period in the previous year, the business posted $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. Research analysts expect that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other news, COO Sanjay Gajendra sold 280,000 shares of the business's stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the completion of the sale, the chief operating officer owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. The trade was a 4.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Michael Truett Tate sold 100,000 shares of the stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $171.38, for a total value of $17,138,000.00. Following the transaction, the chief financial officer owned 518,996 shares of the company's stock, valued at approximately $88,945,534.48. This trade represents a 16.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,576,713 shares of company stock worth $239,237,016. 12.50% of the stock is owned by insiders.

Astera Labs Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.